Actively Recruiting
Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances
Led by Vanda Pharmaceuticals · Updated on 2024-03-20
1000
Participants Needed
1
Research Sites
778 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
CONDITIONS
Official Title
Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Parent or legal guardian of individual with Smith-Magenis Syndrome
You will not qualify if you...
- Not legal guardian of individual with SMS
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vanda Pharmaceuticals
Washington D.C., District of Columbia, United States, 20037
Actively Recruiting
Research Team
V
Vanda Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here